BASF announces cash offer to acquire Pronova BioPharma
BASF announces cash offer to acquire Pronova BioPharma BASF to achieve leading position in omega-3 fatty acids Cash offer of NOK 12.50 per share Offer unanimously recommended by Pronova`s Board of Directors and management Pre-acceptance by approximately 60% of share capital
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.